Cart
sales@molnova.com
Noscapine
CAS No. 128-62-1
Noscapine( (SR)-Noscapine | Narcotine )
Catalog No. M21130 CAS No. 128-62-1
Noscapine is a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNoscapine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNoscapine is a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.
-
DescriptionNoscapine is a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.
-
In Vitro——
-
In Vivo——
-
Synonyms(SR)-Noscapine | Narcotine
-
PathwayAutophagy
-
TargetSigma receptor
-
Recptorσ-receptor
-
Research Areacancer
-
IndicationNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia
Chemical Information
-
CAS Number128-62-1
-
Formula Weight413.42
-
Molecular FormulaC22H23NO7
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (72.57 mM)
-
SMILESCOc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C
-
Chemical Name(S)-67-dimethoxy-3-((R)-4-methoxy-6-methyl-5678-tetrahydro-[13]dioxolo[45-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Altinoz MA Topcu G Hacimuftuoglu Aet al.Noscapine a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma.Neurochem Res. 2019 Aug;44(8):1796-1806.
molnova catalog
related products
-
MIN-101
MIN-101 (Roluperidone, CYR-101, MT-210) is a higly potent 5-HT2A and sigma 2 receptor antagonist.
-
Sigma-1 receptor ant...
Sigma-1 receptor antagonist 3 is a more potent and selective antagonist of Sigma-1 (σ1) receptor (Ki = 1.14 nM) than σ2 receptor(Ki = 1239 nM).
-
Glycerol phenylbutyr...
Glycerol phenylbutyrate (GPB) is a new generation ammonia scavenger drug and it also is a sigma-2 (σ2) receptor ligand (pKi: 8.02).Glycerol phenylbutyrate may have therapeutic potential in additional conditions such as chronic hepatic encephalopathy or other inherited metabolic disorders. Glycerol phenylbutyrate also has the potential for the treatment of hyperammonemia.
